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Physical examination showed normal vital 
signs, but her left hand was atrophic with tight, 
shiny anesthetic skin and pencil-like fi ngers. We did 
not fi nd any arthritis or tremor. She had no leonine 
facies or any skin lesion on other parts of her body.
Laboratory examination revealed: hemoglobin 
12.5 g/dL, hematocrit 37.5%, leukocyte count 7.9 × 
103/mm3, platelet count 287 × 103/mm3, erythrocyte 
sedimentation rate 35 mm/hr, C-reactive protein 
4.6 mg/dL, blood glucose 102 mg/dL, blood urea 
nitrogen 30 mg/dL, serum creatinine 0.5 mg/
dL, aspartate aminotransferase 44 IU/L, alanine 
aminotransferase 31 IU/L, total protein 7.8 U/
L, albumin 4.41 U/L, globulin 3.49 U/L, total 
cholesterol 161 mg/dL, low-density lipoprotein 
cholesterol 63 mg/dL, and high-density lipoprotein 
cholesterol 71 mg/dL. The urinalysis showed 
normal results. The latex rheumatoid factor test was 
negative. Antinuclear antibodies were negative and 
there were no antibodies toward extractable nuclear 
antigens. Radiography of the hands and wrists 
showed normal bones. 
The patient was fi rst diagnosed with vasculitis 
and carpal tunnel syndrome. However, we found no 
histopathologic feature of vasculitis on biopsy. The 
electromyography did show motoric neuropathy of 
the median nerve and sensoric neuropathy of the 
ulnar nerve, but we found no swelling of the lining 
of the fl exor tendons (tenosynovitis) or evidence 
of joint dislocations, fractures, or arthritis that can 
narrow the carpal tunnel and put pressure on the 
nerve.  She was then given steroid (prednisolone 32 
mg/day) and calcium 1,500 mg/day.
One month after therapy, she complained of 
gradual pain, stiffness, swelling, and redness of 
fi ngers II and III of her left hand. There was no clear 
history of Raynaud’s phenomenon. On physical 
Leprosy patients could display a great variability 
of signs and symptoms. An overabundance of 
rheumatic manifestations, occuring alone or in 
varying combinations, are associated with leprosy, 
particularly with lepra reactions A study involving 
seventy cases of leprosy found that rheumatic 
manifestations were seen in 61.42% of cases: 
arthritis in 54.28% and soft tissue rheumatism in 
17.14%. Enthesitis was seen in 2.84% of cases. 
Rheumatic manifestations may be the primary 
complaint, thus delaying accurate diagnosis. 
Musculoskeletal involvement in leprosy is the third 
most frequent manifestation after dermatological 
and neurological involvements. It can occur at any 
time during the infection. Articular infl ammation 
in leprosy, which closely mimics other rheumatic 
disorders, usually occurs in reactive states, 
particularly erythema nodosum leprosum (ENL).1 
About 1–5% of leprosy patients are reported of 
developing arthritis (synovial infl ammation) at 
some stage of the disease but this rate increases to 
over 50% during lepra reactions.2
Here we report a case of arthritis in leprosy 
without any typical skin lesion thus causing a delay 
in diagnosis.
CASE REPORT
A 72-year-old woman was admitted at the 
immunology clinic complaining that her left hand 
had become smaller than her right hand within one 
year. The skin on her left hand was anesthetic with 
occasional tingling sensation. She reported no skin 
lesion on other parts of her body. There were not 
any signifi cant constitutional symptoms and family 
history of arthritis or leprosy. 
Figure 1   Muscle atrophy of the left hand with tight 
and shiny skin.
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Figure 2   Arthritis of fi ngers II and III of the left hand. 
The size of both hands had become similar.
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examination we found swelling of the fi ngers of her left hand, 
with arthritis of interphalangeal joints of fi ngers II and III 
(fi gure 2). Still there was no typical skin lesion on the fi ngers 
or on any other parts of her body.
She then underwent slit skin smear for acid-fast bacilli, 
which showed negative result. Skin biopsies were subsequently 
performed and histopathological examination revealed 
thickening of collagen and epitheloid granuloma in dermis, 
thus representing scleroderma, but borderline tuberculoid 
(BT) leprosy was also suspected. Fite-Faraco staining showed 
no acid-fast bacilli. She then underwent serological test with 
enzyme-linked immunosorbent assay (ELISA) for anti–
phenolic glycolipid-I (anti–PGL-I). We found that IgM was 
normal (456 U/mL, cut off 605 U/mL) but there was slight rise 
of IgG (666 U/mL, cut off 630 U/mL). The diagnosis of BT 
leprosy was then made. The World Health Organization (WHO) 
multidrug therapy (MDT) 1982 regimens for paucibacillary 
(PB) leprosy, comprising of rifampicin 600 mg once a month 
and dapsone 100 mg q.d., was started immediately.
Five months after therapy, the size of both hands had 
become similar. Her arthritis symptoms had improved, 
although the complaint of recurrent numbness and tingling on 
her left hand persisted (fi gure 3). The dose of prednisolone 
was then tapered and MDT for PB was continued.
  
Figure 3   Five months after therapy: similar sizes of both hands, 
with swelling of fi ngers II and III of the left hand.
DISCUSSION
Leprosy, or Hansen’s disease (HD), is a chronic granulomatous 
infection caused by Mycobacterium leprae. It has a global 
prevalence of 5.7 per 10,000 populations. At the end of 2005, 
the global prevalence of leprosy was estimated by the WHO 
to be around 1 per 10,000 population.3 It is estimated that 12–
20 million people suffer from leprosy worldwide. Leprosy is 
endemic in Indonesia. Data from the Ministry of Health of the 
Republic of Indonesia showed that the prevalence of leprosy 
in Indonesia was 0.76/10,000 population in 2008.4
Leprosy exhibits a wide spectrum of presentation, 
varying from the tuberculoid to the lepromatous pole, with 
immunologically unstable borderline forms in between, 
depending upon the immunity status of the individual. 
Traditionally, patients are classifi ed according to the 
Ridley-Jopling scale, which includes indeterminate leprosy, 
tuberculoid leprosy, borderline tuberculoid leprosy, borderline 
leprosy, borderline lepromatous leprosy, and lepromatous 
leprosy. Tuberculoid leprosy represents a suffi cient cell-
mediated immune response. Patients may have one or two 
hypopigmented, erythematous, and anesthetic macules with 
a raised margin. Lepromatous leprosy may occur in the 
setting of immune dysfunction or if the patient is anergic to 
M. leprae. These patients may have widespread disease that 
involves the skin, upper respiratory tract, anterior chamber 
of the eye, testes, lymph nodes, periosteum, and superfi cial 
sensory and motor nerves.5,6 Cutaneous fi ndings include 
diffuse, erythematous macules, papules, and nodules. The 
clinical system of classifi cation for the purpose of treatment 
includes the number of skin lesions and nerves involved as 
the basis for classifying the patients into multibacillary (MB) 
or PB.7,8,9
The presentation of leprosy can be variable. The skin 
lesions of leprosy have a great similarity to various other 
lesions, hence the term “the great imitator”. Sometimes, these 
skin lesions may be misdiagnosed because the physician does 
not consider leprosy. Although leprosy affects primarily the 
skin and the peripheral nervous system, it also secondarily 
involves the liver, spleen, testes, kidney, bone marrow, and 
eyes.5,6 Any peripheral or cutaneous nerve may be involved, 
but the ulnar nerve is the most commonly affected. In addition, 
leprosy patients may also suffer from reactions which are acute 
episodic infl ammatory states unrelated to secondary infection 
and which occurs during the natural course of the disease.5,6,10
The diagnosis of our patient was delayed because she 
had no symptom of arthritis or typical leprosy skin lesion 
before being treated with systemic corticosteroids. The 
diagnosis was confused clinically because she had developed 
neurological signs with atrophy of the left hand without the 
evidence of vasculitis or carpal tunnel syndrome. Although 
histopathological examination of skin biopsy revealed the 
presence of epitheloid granuloma, the diagnosis of BT leprosy 
was still doubted. The diagnosis of leprosy was fi nally made by 
serological test with ELISA, in which there was a slight rise of 
IgG anti–PGL-I. It fi tted the theory that the rapid lateral fl ow 
test for anti–PGL-I antibody of M. leprae was highly positive 
at the beginning and moderately positive at the follow-up.11
In BT leprosy, infl ammation associated with active and 
reactive BT lesions may usually cause asymmetrical swelling 
of the hands and feet, particularly if the skin lesions are present 
at these sites.6,12 Our patient had asymmetrical oligoarthritis 
even though there was not any identifi able active leprosy skin 
lesion on the site of arthritis. 
Pathogenesis of arthritis in leprosy remains unclear until 
now. Some experts stated that arthritis in leprosy is a reactive 
arthritis with immunological basis. Some others classifi ed 
it as infective arthritis based on the presence of leprosy 
bacilli in synovial tissue or joint fl uid. Arthritis could present 
either within a reactional state or without the reaction.13 The 
pathological effects of leprosy on the skeleton are primarily 
a consequence of neuropathy leading to denervation, direct 
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bony changes, secondary infection and the sequelae of trophic 
ulcers.14
In patient with leprosy, the following superfi cial 
peripheral nerve trunks may be palpably hypertrophied: 
facial, great auricular (neck), ulnar (elbow), median (wrist), 
radial cutaneous (wrist), lateral popliteal (neck of fi bula), 
and posterior tibial (medial malleolus). The most commonly 
affected is the posterior tibial nerve followed by the ulnar 
nerve at the elbow, whose involvement results in clawing of 
the fourth and the fi fth fi ngers, and loss of dorsal interosseous 
musculature and loss of feeling in the ulnar nerve distribution. 
Median nerve involvement impairs thumb opposition and 
grasp, while radial nerve dysfunction, though rare in leprosy, 
results in wristdrop. Three major nerve branches supply 
sensory and motor function to the hand and arm, listed in order 
of the frequency of their involvement in leprosy: the ulnar, the 
median and the radial nerve branches. Abnormality in any one 
of these peripheral nerve branches can result in a change from 
a normal sensory feedback and muscle function of the hand. 
Leprosy patients are somewhat unique in that they can also 
develop temperature-associated loss of sensory end-organs 
superfi cially in skin in areas not typical to a specifi c peripheral 
nerve area of innervation. On the palm in early stages of 
the disease, a loss of feeling has most often been related to 
specifi c nerve branches, thus an ulnar, median, or radial nerve 
loss. While leprosy can affect the peripheral nerve branches 
or superfi cial areas of the skin, other diseases and injuries 
can affect the same peripheral nerve branches. Information 
learned from patients with multiple nerve involvement has 
increased our understanding of the normal hand and of the 
role insensitivity and muscle loss plays in deformity and 
disability. An understanding of the mechanics of deformity 
from sensory and motor loss provides insight into prevention 
and correction.3
Specifi c bony lesions in leprosy are rare with an incidence 
of between 3 and 5% among hospitalized patients, and are 
mainly confi ned to the small bones of the face, hands and 
feet. These lesions are characterized by granulomatous tissue 
reactions, which are destructive and manifest radiographically 
as focal areas of increased rarefaction. The margins are thin, 
but may be sclerotic. Obliteration of the cavity may result from 
its collapse with fl attening of the articular surface. In the hands 
and feet, the disease mainly involves the proximal and/or the 
middle phalanges. It may present as thinning of the endosteum 
with corresponding widening of the medullary canal localised 
to the area of the metaphysis. Fusiform swelling of the soft 
tissues overlying the corresponding part of the affected digit is 
more common. This is occasionally associated with enlarged 
nutrient foramina. Leprous osteitis in the hands commonly 
involves the distal ends of the proximal and middle phalanges, 
whereas it usually affects the metatarsal heads in the feet. 
If the disease progress and the trabeculae be destroyed, the 
radiographs reveal a “honeycomb and cystic” appearance. 
With healing, radiographic changes become sharply defi ned 
as cysts with sclerotic margins. The articular surface can also 
be involved and the intrinsic forces in the hand may result in 
fracture, subluxations and rigid clawing of the fi ngers.10,12–14 
In our patient there is no lesion on the hand radiograph.
It is vital to prevent the development of nerve palsies and 
ulcers. Primary prevention is by early detection and the use of 
antileprosy drugs. Secondary prevention is by health education 
and self-awareness of the patient; hygiene of the anaesthetic 
foot with attention to cracks and fi ssures, early detection of 
tenderness and adequate rest; awareness of potential injury 
mainly during work and cooking; appropriate foot wear.14
Multidrug therapy is the mainstay of treatment. The 
current multidrug therapy recommended by the WHO in 
adults with MB disease is rifampicin 600 mg orally once a 
month, dapsone 100 mg orally daily, and clofazimine 300 mg 
orally once monthly with additional 50 mg daily. The WHO 
recommends that it be continued for 12 months but patients 
with initial high bacterial loads may need longer treatment. 
For PB disease (bacteriological index 2+) the regimen is 
rifampicin 600 mg orally once monthly and dapsone 100 mg 
orally daily for six months. 
Any patient who develops peripheral nerve damage during 
the last six months of treatment should receive a four- to six-
month course of oral steroids. 
There is usually stiffness of the fi ngers. Physiotherapy 
with active exercises, massage, passive stretching and wax 
baths and splinting should be undertaken before giving 
consideration to tendon transfer procedures. 
Impairment of nerve function can occur before diagnosis and 
during or after multidrug therapy. Patients with multibacillary 
leprosy and pre-existing nerve damage are at the highest risk 
of impairment of nerve function during and after treatment. 
These patients should be under surveillance for two years from 
diagnosis. Regular clinical evaluation should include nerve 
palpation, motor testing of the small muscles of the hand. 
Steroids may also be given to reduce infl ammation.3,6 After 
the treatment with MDT for PB disease and continued with 
low-dose steroid (4 mg/day), her joint disease had responded 
well but she had permanent neurological damage presented 
as recurrent numbness and tingling of her left hand, some 
of which might have been avoided if the diagnosis had been 
made earlier. 
CONCLUSION
Symmetric polyarthritis involving the peripheral joints is the 
most common rheumatic manifestation in leprosy patients. 
This article reported the case of a patient affected with leprosy 
who developed asymmetrical oligoarthritis without any of the 
skin lesions characteristic of leprosy infection. There was a 
delay in diagnosis because of nonspecifi c feature that resulted 
in persistent nerve damage, which might have been prevented 
if the diagnosis had been made earlier.
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